Hyundai Feed
016790.KQ
0.75 USD
-0.01
-1.32%
h
Overview
Last close
0.75 usd
Market cap
141.92M usd
52 week high
9.78 usd
52 week low
0.69 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.0567
Price/Book Value
3.7373
Enterprise Value
222.65M usd
EV/Revenue
1.794
EV/EBITDA
-1.0901
Key financials
Revenue TTM
113.61M usd
Gross Profit TTM
12.63M usd
EBITDA TTM
-13.08M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
101.14B usd
Net debt
N/A usd
About
HYUNDAI FEED Inc. engages in the manufacture and sale of formulated feed. Its primary products include poultry and pig feed. The company also engages in the biopharmaceutical business. In addition, it focuses on the development and commercialization of immunotherapies for cancer. Further, the company's lead product includes oregovomab, an immunotherapy for ovarian cancer. Additionally, it is involved in the developing AR20.5, which treatment of pancreatic cancer. The company was formerly known as CANARIABIO Inc. and changed to HYUNDAI FEED Inc. on January 2024. The company was founded in 1983 and is headquartered in Seoul, South Korea.
- Symbol016790.KQ
- ExchangeKQ
- IsinKR7016790008
- CountrySouth Korea
- SectorConsumer Defensive
- IndustryPackaged Foods
- CEO
- HeadquarterSeoul
- Web sitehttps://www.canariabio.com
Related news
December 21
JAKOTA Stocks on December 20, 2023 December 13
JAKOTA Stocks on December 13, 2023 